Matches in Wikidata for { <http://www.wikidata.org/entity/Q65365653> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q65365653 description "clinical trial" @default.
- Q65365653 description "ensayu clínicu" @default.
- Q65365653 description "klinisch onderzoek" @default.
- Q65365653 description "клінічне випробування" @default.
- Q65365653 name "A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]" @default.
- Q65365653 name "A Study of Atezolizumab in Participants With Programmed Death-Ligand 1" @default.
- Q65365653 type Item @default.
- Q65365653 label "A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]" @default.
- Q65365653 label "A Study of Atezolizumab in Participants With Programmed Death-Ligand 1" @default.
- Q65365653 prefLabel "A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]" @default.
- Q65365653 prefLabel "A Study of Atezolizumab in Participants With Programmed Death-Ligand 1" @default.
- Q65365653 P1132 Q65365653-0A9B6CEC-AC71-4947-95FC-1CED04EC231A @default.
- Q65365653 P1476 Q65365653-305438F0-4667-419B-B16F-5C97F04740AA @default.
- Q65365653 P17 Q65365653-06346CFF-3F4A-4753-8334-D0A27A3CC6B2 @default.
- Q65365653 P17 Q65365653-24B8F172-B036-4584-8674-4E999B7346A3 @default.
- Q65365653 P17 Q65365653-645C2DF8-94FA-498C-8951-0E8ED8ABB80F @default.
- Q65365653 P17 Q65365653-DC50BD0B-C445-4FB7-9C18-6853447D4A7F @default.
- Q65365653 P17 Q65365653-ED94DDE9-E8C3-442B-B0B0-E466507E8D3F @default.
- Q65365653 P2899 Q65365653-0E827279-32B9-43A3-9616-CC567411CE9D @default.
- Q65365653 P3098 Q65365653-E7C77E19-296E-4949-8076-57FD4E8B17FD @default.
- Q65365653 P31 Q65365653-78D9BDBA-3908-4563-BE1B-39E46C6FAB4F @default.
- Q65365653 P580 Q65365653-2A6E6EDB-B9D4-44AF-B0A9-3C14F80F6219 @default.
- Q65365653 P582 Q65365653-E400D3AB-70E5-45B9-BF8B-97967C0C2428 @default.
- Q65365653 P6099 Q65365653-1034CE61-2A9C-4064-BB32-FB0F6CC3F417 @default.
- Q65365653 P6153 Q65365653-1B39BBBC-5E51-4EC0-B2C9-8DB98C8632E7 @default.
- Q65365653 P6153 Q65365653-2670C0C4-ED2F-4452-B1FC-7130AF8463BF @default.
- Q65365653 P6153 Q65365653-470CD844-6FEB-4F51-8F2F-8EAEE30B1A78 @default.
- Q65365653 P6153 Q65365653-5841738F-30B1-4A1E-897A-E755B09876A0 @default.
- Q65365653 P6153 Q65365653-59BDE278-D0EC-46EB-8509-48EA9AAA971A @default.
- Q65365653 P6153 Q65365653-6150BDDC-6701-4A37-A329-C35F97868CC1 @default.
- Q65365653 P6153 Q65365653-7BF45D6E-E252-46BB-B331-E8AF90DA3837 @default.
- Q65365653 P6153 Q65365653-843D9C09-C1A0-406D-A58A-8C5A927A0701 @default.
- Q65365653 P8363 Q65365653-7D4050C6-EC6A-4D21-B3A8-ECA3AAE25D05 @default.
- Q65365653 P1132 "+138" @default.
- Q65365653 P1476 "A Phase II, Multicenter, Single-arm Study of MPDL3280A in Patients With PD-L1-Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer" @default.
- Q65365653 P17 Q142 @default.
- Q65365653 P17 Q145 @default.
- Q65365653 P17 Q30 @default.
- Q65365653 P17 Q31 @default.
- Q65365653 P17 Q55 @default.
- Q65365653 P2899 "+18" @default.
- Q65365653 P3098 "NCT01846416" @default.
- Q65365653 P31 Q30612 @default.
- Q65365653 P580 "2013-05-30T00:00:00Z" @default.
- Q65365653 P582 "2015-01-07T00:00:00Z" @default.
- Q65365653 P6099 Q42824440 @default.
- Q65365653 P6153 Q131252 @default.
- Q65365653 P6153 Q1468161 @default.
- Q65365653 P6153 Q1808012 @default.
- Q65365653 P6153 Q195668 @default.
- Q65365653 P6153 Q2536586 @default.
- Q65365653 P6153 Q333886 @default.
- Q65365653 P6153 Q49117 @default.
- Q65365653 P6153 Q5312891 @default.
- Q65365653 P8363 Q78089383 @default.